Overview

Response to Clenbuterol in Humans

Status:
Recruiting
Trial end date:
2022-03-15
Target enrollment:
Participant gender:
Summary
Due to the long half-life (~36 hr) of clenbuterol, detection methods such as dried blood spots (DBS) are a potentially suitable method to easily and non-invasively detect doping misuse of this compound for several days after ingestion. If, and how long, the compound can be detected by DBS has not yet been investigated but is of interest due to its potential in doping-control. The aim is to evaluate whether abuse of clenbuterol can be detected at relevant concentration levels in samples obtained using DBS and to assess the physiological response to clenbuterol in skeletal muscle..
Phase:
N/A
Details
Lead Sponsor:
University of Copenhagen
Treatments:
Clenbuterol